EDGAR 10-K Filing

Company CIK: 1593773
Filing Year: 2025
Filename: 1593773_10-K_2025_0001477932-25-001401.json

---

ITEM 1. BUSINESS
Item1: Description of Business
General Overview
AMJ Global Technology (the ‘Company’, “we,” and “us) was incorporated under the laws of the State of Nevada on August 16, 2013, originally incorporated as Kange Corp. Effective April 22, 2023, the Company filed with the State of Nevada a Certificate of Amendment to its Articles of Incorporation, changing the name of the Company to AMJ Global Technology.
We are a start-up company developing mobile software products, starting in Estonia and Europe, which is our initial intended market. During year 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry, revenue sharing generated from Medicare enrollees, life and annuity insurance sales, and having 8% right and interest on software, certain additional and related assets belonged to a technology company specializing in the development of an advanced database called ElephantSqlDB® designed to leverage AI and quantum computing performance through a specialized architecture and algorithm called the Grover’s Algorithm. The ElephantSqlDB® database is unique in that is a single database that performs multiple database functions such as supporting 11 SQL dialects in addition to artificial intelligence (AI) data storage, SQL and NoSQL queries. The object of technology assets is to target and cut cloud infrastructure costs significantly while providing immutable security in-order to combat evolving threats such as ransomware attacks.
On November 9, 2015, AMJ Global, LLC (“AMJ Global”), a company beneficially owned by Dr. Arthur Malone, Jr., the Company’s chief executive officer and director, assigned the rights of AMJ Global pursuant to its agreements with Blabeey, Inc. (“Blabeey”), a mobile App designer. The irrevocable assignment, transferred and conveyed in its entirety to the Company in a common control transaction, all of AMJ Global’s rights and obligations that are stipulated and set forth in every and all agreements between AMJ Global and Blabeey, including, but not limited to, the agreement between AMJ Global and Blabeey dated October 26, 2015. Blabeey’s web site is www.blabeey.com, which is not incorporated in this filing. The Company issued 5,000,000 shares of common stock to AMJ Global for the assignment. The Company valued those shares at $471,672, the historical asset costs of Blabeey. Since the Company’s transaction with AMJ Global was between entities under common control, the amount of the historical cost of the assets, $471,672, was recorded as an expense in 2015 as there was no fixed and determinable future value, and the expense was recorded as a loss on the acquisition of contractual rights. Subsequently, the Company began working with Blabeey on developing technology for social media regarding Autism, PTSD and other neurological issues, and the Company is still consulting with Blabeey regarding software development opportunities in connection with the wholistic health industry.
The Company reports its business under the following SIC Code:
SIC Code
Description
Computer Systems Design and Related Services
On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director., pursuant to which AMJ Global Entertainment, LLC assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.
Our corporate headquarters are located at 2470 E Flamingo Rd., Suite A Las Vegas, NV 89121.
Reports to Security Holders
We intend to furnish our shareholders annual reports containing financial statements audited by our independent registered public accounting firm and to make available quarterly reports containing unaudited financial statements for each of the first three quarters of each year. We file Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K with the Securities and Exchange Commission in order to meet our timely and continuous disclosure requirements. We may also file additional documents with the Commission if they become necessary in the course of our company’s operations.
The public may read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is www.sec.gov.
Government Regulations
We believe that we are and will continue to be in compliance in all material respects with applicable statutes and the regulations passed in the United States. There are no current orders or directions relating to our company with respect to the foregoing laws and regulations.
Environmental Regulations
We do not believe that we are or will become subject to any environmental laws or regulations of the United States. While our products and business activities do not currently violate any laws, any regulatory changes that impose additional restrictions or requirements on us or on our products or potential customers could adversely affect us by increasing our operating costs or decreasing demand for our products or services, which could have a material adverse effect on our results of operations.
Employees
As of November 30, 2024, we had no full-time employees.
Property
We do not have any real property that we lease or own.

---

ITEM 1A. RISK FACTORS
Item 1A. Risk Factors
As a smaller reporting company, we are not required to provide the information required by this item.

---

ITEM 1B. UNRESOLVED STAFF COMMENTS
Item 1B. Unresolved Staff Comments.
None.

---

ITEM 2. PROPERTIES
Item 2. Properties
We do not own any real estate or other properties.

---

ITEM 3. LEGAL PROCEEDINGS
Item 3. Legal Proceedings
Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Annual Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us or our properties.

---

ITEM 4. MINE SAFETY DISCLOSURE
Item 4. Mine Safety Disclosures
Not applicable to our Company.
PART II

---

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY
Item 5. Market for Common Equity and Related Stockholder Matters
Market Information
The Company’s common stock is traded on the OTC Link ATS (the alternative trading system operated by OTC Markets Group, Inc). under the symbol “AMJT.” As of January 19, 2023, the Company’s common stock was held by 119 shareholders of record, which does not include shareholders whose shares are held in street or nominee name.
The Company’s shares commenced trading on or about December 31, 2014. The following chart is indicative of the fluctuations in the stock prices:
For the Years Ended November 30
High
Low
High
Low
First Quarter
$ 1.90
$ 1.25
$ 1.50
$ 1.40
Second Quarter
$ 1.94
$ 0.25
$ 2.25
$ 0.30
Third Quarter
$ 1.70
$ 0.75
$ 2.20
$ 0.06
Fourth Quarter
$ 1.97
$ 0.30
$ 1.50
$ 1.50
Source: Nasdaq.com
The Company’s transfer agent is Empire Stock Transfer at 1859 Whitney Mesa Dr., Henderson, NV 89014.
Dividend Distributions
We have not paid any cash dividends on our common stock and have no present intention of paying any dividends on the shares of our common stock. Our current policy is to retain earnings, if any, for use in our operations and in the development of our business. Our future dividend policy will be determined from time to time by our board of directors.
Securities authorized for issuance under equity compensation plans.
The Company does not have a stock option plan.
Penny Stock
Our common stock is considered “penny stock” under the rules the Securities and Exchange Commission (the “SEC”) under the Securities Exchange Act of 1934. The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or quoted on the NASDAQ Stock Market System, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or quotation system. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized risk disclosure document prepared by the Commission, that:
·
contains a description of the nature and level of risks in the market for penny stocks in both public offerings and secondary trading;
·
contains a description of the broker’s or dealer’s duties to the customer and of the rights and remedies available to the customer with respect to a violation to such duties or other requirements of Securities’ laws; contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks and the significance of the spread between the bid and ask price;
·
contains a toll-free telephone number for inquiries on disciplinary actions;
·
defines significant terms in the disclosure document or in the conduct of trading in penny stocks; and
·
contains such other information and is in such form, including language, type, size and format, as the Commission shall require by rule or regulation.
The broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with:
·
bid and offer quotations for the penny stock;
·
the compensation of the broker-dealer and its salesperson in the transaction;
·
the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the marker for such stock; and
·
monthly account statements showing the market value of each penny stock held in the customer’s account.
In addition, the penny stock rules that require that prior to a transaction in a penny stock not otherwise exempt from those rules; the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written acknowledgement of the receipt of a risk disclosure statement, a written agreement to transactions involving penny stocks, and a signed and dated copy of a written suitably statement.
These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our stock.
Related Stockholder Matters
Unregistered Sales of Equity Securities
On March 28,2024, 400,000 shares of common stock were issued to the Company’s board of directors, valued at $1,048.
On March 28,2024, 200,000 shares of common stock were issued to the Company’s advisory board members, valued at $524.
On April 3,2024, 200,000 shares of common stock were issued to the Company’s advisory board members, valued at $524.
On May 28, 2024, 100,000 shares of common stock were issued against management fees payable to the Company’s CEO and director, valued at $262.
On May 28,2024, 102,200 shares of common stock were issued against amounts owed to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, valued at $268.
On July 10,2024, 133,334 shares of common stock were issued for Medicare contracts asset, a revenue sharing agreement - related party, valued at $337.
On August 6, 2024, 2,000,000 shares of common stock were issued to the Company’s CEO and director, valued at $5,056.
On August 6,2024, 28,2024, 250,000 shares of common stock were issued to the Company’s board of directors, valued at $631.
On August 6,2024, 30,000 shares of common stock were issued to the Company’s advisory board members, valued at $76.
On August 26,2024, 1,333,333 shares of common stock were issued for software and development acquisition, valued at $3,371
The forgoing securities were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder, as there was no general solicitation, and the transactions did not involve a public offering.
Purchase of Equity Securities
None.

---

ITEM 6. SELECTED FINANCIAL DATA
Item 6. [Reserved]

---

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Annual Report on Form 10-K contains forward-looking statements within the meaning of Rule 175 of the Securities Act of 1933, as amended, and Rule 3b-6 of the Securities Act of 1934, as amended, that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as “anticipate,” “expects,” “intends,” “plans,” “believes,” “seeks” and “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Form 10-K. Investors should carefully consider all of such risks before making an investment decision with respect to the Company’s stock. The following discussion and analysis should be read in conjunction with our financial statements and summary of selected financial data for Kange Corp. Such a discussion represents only the best present assessment from our Management.
DESCRIPTION OF COMPANY
AMJ Global Technology (the ‘Company’) was incorporated under the laws of the State of Nevada on August 16, 2013, originally incorporated as Kange Corp. Effective April 22, 2023, the Company filed with the State of Nevada a Certificate of Amendment to its Articles of Incorporation, changing the name of the Company to AMJ Global Technology. We are a start-up company developing mobile software products, starting in Estonia and Europe, which is our initial intended market. During year 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry, revenue sharing generated from Medicare enrollees, life and annuity insurance sales, and having 8% right and interest on software, certain additional and related assets belonged to a technology company specializing in the development of an advanced database called ElephantSqlDB® designed to leverage AI and quantum computing performance through a specialized architecture and algorithm called the Grover’s Algorithm. The ElephantSqlDB® database is unique in that is a single database that performs multiple database functions such as supporting 11 SQL dialects in addition to artificial intelligence (AI) data storage, SQL and NoSQL queries. The object of technology assets is to target and cut cloud infrastructure costs significantly while providing immutable security in-order to combat evolving threats such as ransomware attacks.
On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director, pursuant to which AMJ Global Entertainment assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.
We have had limited operations and have been issued a “going concern” opinion by our auditor, based upon our reliance on the sale of our common stock and advances from related parties as the sole sources of funds for our operations for the near future.
The following Management Discussion and Analysis should be read in conjunction with the financial statements and accompanying notes included in this Form 10-K.
COMPARISON OF THE YEAR ENDED NOVEMBER 30, 2024, TO THE YEAR ENDED NOVEMBER 30, 2023
Results of Operations
The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with the consolidated financial statements and notes thereto for the years ended November 30, 2024 and 2023, and related management discussion herein.
Our consolidated financial statements are stated in U.S. Dollars and are prepared in accordance with generally accepted accounting principles of the United States (“GAAP”).
Going Concern Qualification
Several conditions and events cast substantial doubt about the Company’s ability to continue as a going concern. The Company has incurred cumulative net losses of $476,274 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to raise additional capital through debt or future issuances of capital stock is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raises substantial doubt about the Company’s ability to continue as a going concern.
Our operating results for the years ended November 30, 2024 and 2023, and the changes between those periods for the respective items, are summarized as follows:
Year Ended
November 30,
Change
Amount
Revenue-related party
$ 39
$ -
$ 39
Operating loss
$ 183,845
$ 166,065
$ 17,780
Other income
(98,109 )
(29,276 )
(68,833 )
Net loss
$ 85,697
$ 136,789
$ (51,092 )
Revenues
On July 13, 2024, the Company entered into a Revenue Sharing agreement with a company controlled by a related party, pursuant to which the Company will receive 5% of net revenue generated from two contracts with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of North Georgia in connection with Medicare, life and annuity insurance sales. For the period of July 13, 2024 (inception) to November 30, 2024, the Company recognized $39 revenue in connection with 5% net revenue generated from two contracts.
We did not earn any revenues during the year ended November 30, 2023.
Operating Loss
The Company’s operating loss increased to $183,845 during the year ended November 30, 2024, from an operating loss of $166,065 during the year ended November 30, 2023. The increase in operation loss was attributed to an increase in operating expenses of $17,780 reduced by an increase in revenue of $39.
During the years ended November 30, 2024 and 2023, our operating expenses were primarily attributed to stock-based compensation to our CEO and board advisors of $7,859 and $8,992, accrued management fee of $120,000 and $110,000, professional fees of $44,289 and $39,773 and general and administrative expenses of $11,697 and $7,300, respectively.
Other Income
The following table presents other income for the years ended November 30, 2024, and 2023:
Year Ended
November 30,
Change
Amount
Gain on settlement of debt - related party
$ 98,109
$ 19,302
$ 78,807
Gain on settlement of debt
-
9,974
(9,974 )
Total Other Income
$ 98,109
$ 29,276
$ 68,833
During the years ended November 30, 2024 and 2023, the other income was attributed to gain on the settlement of debt to a company controlled by our CEO of $48,371 and 19,302, gain on settlement of management fess payable to our CEO of $49,738 and $0, and gain on settlement of debt to a vendor of $0 and $9,974, respectively.
Net Loss
The Company incurred a net loss of $85,697 during the year ended November 30, 2023, compared to a net loss of $136,789 for the year ended November 30, 2023. The decrease in net loss was due to an increase in operating expenses of $17,780 offset by an increase in revenue of $39 and other income of $68,833, as described above.
Liquidity and Capital Resources
Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all.
Working Capital
The following table presents our working capital position as of November 30, 2024 and 2023:
As of
As of
November 30,
November 30,
Change
Amount
Current assets
$ 5,545
$ 9,140
$ (3,595 )
Current liabilities
$ 200,928
$ 127,215
$ 73,713
Working capital (deficiency)
$ (195,383 )
$ (118,075 )
$ 77,308
The change in working capital during the year ended November 30, 2024, was primarily due to an increase in current liabilities of $73,713 and a decrease in current assets of $5,545.
As of November 30, 2024, current liabilities were comprised of $4,762 in accounts payable and accrued liabilities, $16,166 in due to related party and $180,000 in accrued management fee - related party, compared to $750 in accounts payable, $16,465 in due to related party and $110,000 in accrued management fee - related party as of November 30, 2023.
Cash Flow
We fund our operations with cash received from advances from officers and related parties and issuances of equity.
The following tables presents our cash flow for the years ended November 30, 2024 and 2023:
Year Ended
November 30,
Cash used in operating activities
$ (48,114 )
$ (51,118 )
Cash provided by financing activities
48,340
51,118
Net change in cash for the period
$ 226
$ -
Cash Flows from Operating Activities
We did not generate positive cash flows from operating activities for the years ended November 30, 2024 or 2023.
For the year ended November 30, 2024, net cash flows used in operating activities consisted of a net loss of $85,697, reduced by stock-based compensation - related party of $7,859 and increased by a gain on settlement of debt - related party of $98,109, reduced by a change in prepaid expenses of $3,860 and accounts payable and accrued liabilities of $124,012.
For the year ended November 30, 2023, net cash flows used in operating activities consisted of a net loss of $136,789, reduced by stock-based compensation - related party of $8,993 and increased by a gain on settlement of debt - related party of $19,303, a gain on settlement of debt of $9,974, and increased by a change in prepaid expenses of $9,140, reduced by a change in accounts payable and accrued liabilities of $115,09,.
Cash Flows from Investing Activities
For the years ended November 30, 2024, and 2023, no cashflows were provided by or used in investing activities.
Cash Flows from Financing Activities
During the years ended November 30, 2024, and 2023, AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director advanced to the Company an amount of $48,647 and $51,118, by paying for operating expenses on behalf of the Company and the Company repaid $307 and $0, respectively.
Off-Balance Sheet Arrangements
The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Critical Accounting Estimates and Judgements
Use of Estimates.
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Stock-based compensation.
We account for share-based compensation under the fair value method which requires all such compensation to be calculated based on its fair value at the measurement date (generally the grant date) and recognized in the statement of operations over the requisite service period.
Concentration
As of November 30, 2024 and for the year ended November 30, 2024, customer and revenue concentrations (more than 10%) were 100% related to one revenue sharing agreement with a related party.

---

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Item 7A. Quantitative and Qualitative Disclosures about Market Risk
As the Company is a “smaller reporting company,” this item is inapplicable.

---

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Item 8. Financial Statements and Supplementary Data
AMJ Global Technology
Page
Report of Independent Registered Public Accounting Firm Report (PCAOB ID: 6580)
Balance Sheets
Statement of Operations
Statements of Changes in Stockholders’ Deficit
Statement of Cash Flows
Notes to Financial Statements
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors and Stockholders
AMJ Global Technology
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of AMJ Global Technology (the Company) as of November 30, 2024, and 2023, and the related consolidated statements of operations, consolidated statements of changes in stockholders’ deficit, and consolidated statements of cash flows for the years ended November 30, 2024, and 2023, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of November 30, 2024, and 2023 and the results of its operations and its cash flows for each of the year in the period ended November 30, 2024, and 2023 in conformity with accounting principles generally accepted in the United States of America.
Going Concern
The accompanying financial statements have been prepared assuming that the entity will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has suffered recurring losses from operations and has not yet generated any revenues. This raises substantial doubt about the Company’s ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 2 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that were communicated or required to be communicated to the board of directors and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which they relate.
Issuance of Shares
During the year ended November 30, 2024, the Company issued shares in the aggregate amount of $12,097, through equity transactions.
We deemed our audit over the issuance of share capital as a critical audit matter because of the magnitude of the transactions and the increased extent of auditing effort, in relation to the audit as a whole, to evaluate management’s valuation of the equity transactions.
How the Critical Audit Matter was addressed in the Audit
Our audit procedures related to the issuance of shares transactions included the following, among others:
·
We read the agreements and analyzed the terms of the Company’s equity transactions.
·
We evaluated management’s interpretation and application of the relevant accounting guidance in relation to the appropriateness of the equity valuation of the shares issues in these transactions.
·
We agreed the value with external quotes for comparable transactions.
·
We compared the shares issued and outstanding to the confirmation obtained directly from the transfer agent.
/s/ GreenGrowth CPAs
Los Angeles, California
February 28, 2025
We have served as the Company’s auditor since 2023.
AMJ Global Technology
Consolidated Balance Sheets
November 30,
November 30,
ASSETS
Current Assets
Cash
$ 226
$ -
Accounts receivable - related party
-
Prepaid expenses
5,280
9,140
Total Current Assets
5,545
9,140
Software and technology assets
3,371
-
Medicare contracts asset
-
TOTAL ASSETS
$ 9,253
$ 9,140
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable and accrued liabilities
$ 4,762
$ 750
Accrued management fees - related party
180,000
110,000
Due to related party
16,166
16,465
Total Current Liabilities
200,928
127,215
Stockholders' Deficit
Common stock, $0.001 par value, 750,000,000 shares authorized, 107,782,190 and 103,033,323 shares issued and outstanding, respectively
107,782
103,033
Additional paid-in capital
176,817
169,469
Accumulated deficit
(476,274 )
(390,577 )
Total Stockholders' Deficit
(191,675 )
(118,075 )
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
$ 9,253
$ 9,140
The accompanying notes are an integral part of these financial statements.
AMJ Global Technology
Consolidated Statements of Operations
Year Ended
November 30,
Revenues -related party
$ 39
$ -
Operating Expenses
General and administrative
11,697
7,300
Professional fees
44,289
39,773
Management compensation
127,859
118,992
Total operating expenses
183,845
166,065
Operating loss
(183,806 )
(166,065 )
Other income
Gain on settlement of debt - related party
98,109
19,302
Gain on settlement of debt
9,974
Total other income
98,109
29,276
Net loss before income taxes
(85,697 )
(136,789 )
Provision for income taxes
-
-
Net Loss
$ (85,697 )
$ (136,789 )
Basic and diluted loss per common share
$ (0.00 )
$ (0.00 )
Basic and diluted weighted average common shares outstanding
104,814,980
92,509,487
The accompanying notes are an integral part of these financial statements.
AMJ Global Technology
Consolidated Statement of Changes in Stockholders’ Deficit
Additional
Total
Common Stock
Paid-in
Accumulated
Stockholders'
Shares
Amount
Capital
Deficit
Deficit
Balance - November 30, 2022
89,623,323
$ 89,623
$ 147,412
$ (253,788 )
$ (16,753 )
Common stock issued for settlement of debt- related party
10,000,000
10,000
16,448
-
26,448
Common stock issued for compensation - related party
2,000,000
2,000
3,290
-
5,290
Common stock issued for settlement of debt
10,000
-
Common stock issued for services - related party
1,400,000
1,400
2,303
-
3,703
Net loss
-
-
-
(136,789 )
(136,789 )
Balance - November 30, 2023
103,033,323
$ 103,033
$ 169,469
$ (390,577 )
$ (118,075 )
Common stock issued for software and development acquisition
1,333,333
1,333
2,038
-
3,371
Common stock issued for revenue sharing agreement -related party
133,334
-
Common stock issued for settlement of debt - related party
202,200
-
Common stock issued for compensation - related party
2,650,000
2,650
4,085
-
6,735
Common stock issued for services - related party
430,000
-
1,124
Net loss
-
-
-
(85,697 )
(85,697 )
Balance - November 30, 2024
107,782,190
$ 107,782
$ 176,817
$ (476,274 )
$ (191,675 )
The accompanying notes are an integral part of these financial statements.
AMJ Global Technology
Consolidated Statements of Cash Flows
Year Ended
November 30,
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
$ (85,697 )
$ (136,789 )
Adjustments to reconcile net loss to net cash used in operating activities:
Management compensation
7,859
8,993
Gain on settlement of debt - related party
(98,109 )
(19,302 )
Gain on settlement of debt
-
(9,974 )
Changes in operating assets and liabilities:
Accounts receivable-related party
(39 )
-
Prepaid expenses
3,860
(9,140 )
Accounts payable and accrued liabilities
4,012
5,094
Accrued management fee - related party
120,000
110,000
Net cash used in operating activities
(48,114 )
(51,118 )
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from related party
48,647
51,118
Repayment due to related party
(307 )
-
Net cash provided by financing activities
48,340
51,118
Net change in cash for the period
-
Cash at beginning of period
-
-
Cash at end of period
$ 226
$ -
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes
$ -
$ -
Cash paid for interest
$ -
$ -
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for settlement of debt - related party
$ 530
$ 26,448
Common stock issued for compensation - related party
$ 6,735
$ -
Common stock issued for services - related party
$ 1,124
$ -
Common stock issued for software and development acquisition
$ 3,371
$ -
Common stock issued for revenue sharing agreement -related party
$ 337
$ -
Common stock issued for settlement of debt
$ -
$ 26
The accompanying notes are an integral part of these financial statements.
AMJ Global Technology
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOVEMBER 30, 2024 and 2023
NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY
Business
AMJ Global Technology (the ‘Company’) was incorporated under the laws of the State of Nevada on August 16, 2013, originally incorporated as Kange Corp. Effective April 22, 2023, the Company filed with the State of Nevada a Certificate of Amendment to its Articles of Incorporation, changing the name of the Company to AMJ Global Technology. We are a start-up company developing mobile software products, starting in Estonia and Europe, which is our initial intended market. During year 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry, revenue sharing generated from Medicare enrollees, life and annuity insurance sales, and having 8% right and interest on software, certain additional and related assets belonged to a technology company specializing in the development of an advanced database called ElephantSqlDB® designed to leverage AI and quantum computing performance through a specialized architecture and algorithm called the Grover’s Algorithm. The ElephantSqlDB® database is unique in that is a single database that performs multiple database functions such as supporting 11 SQL dialects in addition to artificial intelligence (AI) data storage, SQL and NoSQL queries. The object of technology assets is to target and cut cloud infrastructure costs significantly while providing immutable security in-order to combat evolving threats such as ransomware attacks.
On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director., pursuant to which AMJ Global Entertainment, LLC assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.
Going Concern
The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company used cash in operating activities of $48,114 for the year ended November 30, 2024. The Company had an accumulated deficit of $476,274 at November 30, 2024. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from related parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts.
The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.
Cash and Cash Equivalents
For purposes of balance sheet presentation and reporting of cash flows, the Company considers all unrestricted demand deposits, money market funds and highly liquid debt instruments with an original maturity of less than 90 days to be cash and cash equivalents. The Company did not have any cash equivalents at November 30, 2024 and 2023. The Company had cash of $226 and $0 at November 30, 2024 and 2023, respectively.
Accounts Receivable
Accounts receivables are recorded in accordance with Financial Accounting Standards Board Accounting Standards Codification (ASC) 310, “Receivables.” Accounts receivables are recorded at the invoiced amount or agreement and do not bear interest. The Company does not currently have any amount recorded as an allowance for doubtful accounts. Based on the management’s estimate and based on all accounts being current, the Company has not deemed it necessary to reserve for doubtful accounts at this time
Revenue Recognition
The Company recognizes revenue from its contracts with customers in accordance with ASC 606 - Revenue from Contracts with Customers. The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.
Revenue related to contracts with customers is evaluated utilizing the following steps:
(i)
Identify the contract, or contracts, with a customer;
(ii)
Identify the performance obligations in the contract;
(iii)
Determine the transaction price;
(iv)
Allocate the transaction price to the performance obligations in the contract;
(v)
Recognize revenue when the Company satisfies a performance obligation.
The Company has one Medicare revenue sharing contract with a related party that requires 5% net revenue generated from two Medicare contracts (Note 3). The Company recognizes the monthly revenue at the beginning of August 2024 with thirty (30) days term of payment.
Equity Investment - Related Party
Equity investments with readily determinable fair values are measured at fair value. Equity investments without readily determinable fair values are measured using the equity method or measured at cost with adjustments for observable changes in price or impairments (referred to as the measurement alternative). We perform a qualitative assessment on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value of the investment is less than carrying value. Changes in value are recorded in other income (expenses).
The Equity investment in AMJ Global Entertainment, LLC (“AMJ”), a related party controlled by the Company’s CEO and director, is accounted for under the equity method as the investment provides us with the ability to exercise significant influence over operating and financial policies of AMJ. On acquisition of AMJ, the investment had no value and as of November 30, 2024, AMJ has sustained losses. The carrying amount of this investment as of November 30, 2024, is $0.
Intangible Assets
Intangible assets with an indefinite life are not amortized and are tested for impairment annually or more frequently if events or changes in circumstances indicate that they might be impaired. Intangible assets with finite lives are initially recorded at cost and amortized on a straight-line basis over the estimated economic useful lives of the respective assets. Acquired intangible assets from business combinations and asset acquisitions are recognized and measured at fair value at the time of acquisition. Those assets represent assets with finite lives and are further amortized on a straight-line basis over the estimated economic useful lives of the respective assets.
Fair Value of Financial Instruments
The Company’s consolidated financial instruments, including accounts payable, accrued expenses, and due to related parties are carried at historical cost. At November 30, 2024 and 2023, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.
Share-Based Expense
ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).
Net Loss per Share of Common Stock
In accordance with ASC 260, “Earnings per Share,” basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period, which are excluded from the computation if anti-dilutive. There are no dilutive or potentially dilutive securities outstanding during the periods presented.
Income Taxes
Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The deferred tax assets of the Company relate primarily to operating loss carryforwards for federal income tax purposes. A full valuation allowance for deferred tax assets has been provided because the Company believes it is not more likely than not that the deferred tax asset will be realized. Realization of deferred tax assets is dependent on the Company generating sufficient taxable income in future periods.
The Company periodically evaluates its tax positions to determine whether it is more likely than not that such positions would be sustained upon examination by a tax authority for all open tax years, as defined by the statute of limitations, based on their technical merits. As of November 30, 2024, and 2023, the Company has not established a liability for uncertain tax positions.
Recent Accounting Pronouncements
The Company reviews new accounting pronouncements as issued. No new pronouncements had any material effect on these financial statements. The accounting pronouncements issued subsequent to the date of these consolidated financial statements that were considered significant by management were evaluated for the potential effect on these consolidated financial statements. Management does not believe any of the subsequent pronouncements will have a material effect on these financial statements as presented and does not anticipate the need for any future restatement of these financial statements because of the retro-active application of any accounting pronouncements issued subsequent to November 30, 2023 through the date these consolidated financial statements were issued.
NOTE 3 - INTANGIBLE ASSETS
As of November 30, 2024, the Company had intangible assets as follows:
November 30,
Software and technology assets
$ 3,371
Medicare contracts asset
$ 3,708
Software and technology assets
On August 25, 2024, the Company entered into a Software Purchase and Development agreement, pursuant to which the Company acquired an 8% interest in database software and related technology assets in exchange for 1,333,333 shares of common stock. The Company issued 1,333,333 shares of common stock on August 26, 2024, valued at $3,371.
For the period of August 25, 2024 (inception) to November 30, 2024, the Company did not earn revenue.
Medicare contracts asset
On July 13, 2024, the Company entered into a Revenue Sharing agreement with a company controlled by a related party, pursuant to which the Company will receive 5% of net revenue generated from two contracts with (i) ESS in connection with Medicare enrollees, and (ii) The Agency of North Georgia in connection with Medicare, life and annuity insurance sales in exchange for 133,334 shares of common stock for a unlimited period. The Company issued 133,334 shares of common stock issued on July 10, 2024, valued at $337.
For the period of July 13, 2024 (inception) to November 30, 2024, the Company recognized $39 revenue in connection with 5% net revenue generated from two contracts.
NOTE 4 - RELATED PARTY TRANSACTIONS
In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such a time that the Company can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are non-interest bearing, considered temporary in nature, and have not been formalized by a promissory note.
On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director, pursuant to which AMJ Global Entertainment assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.
During the years ended November 30,2024 and 2023, AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director advanced to the Company an amount of $47,827 and $51,118, respectively, by paying for operating expenses on behalf of the Company, $820 and $0 in cash and repaid $307 and $0, respectively.
During the years ended November 30,2024 and 2023, the Company accrued management fees of $120,000 and $110,000, respectively.
During the years ended November 30,2024 and 2023, the Company’s board of directors approved the issuance of 102,200 and 10,000,000 shares of common stock for settlement of $48,639 and $45,751 due to AMJ Global Entertainment, LLC, a related party controlled by the Company’s CEO and director, respectively. The shares were valued at $268 and $26,448, resulting in a gain of settlement on debt of $48,371 and 19,302, respectively.
During the year ended November 30, 2024, the Company’s board of directors approved the issuance of 100,000 shares of common stock for settlement of $50,000 management fees payable to the Company’s CEO and director. The shares were valued at $262, resulting in a gain of settlement on debt of $49,738.
During the years ended November 30,2024 and 2023, the Company issued 430,000 and 1,400,000 shares of common stock to advisory board members, the shares were valued and recognized compensation of $1,124 and $3703, respectively.
During the years ended November 30,2024 and 2023, the Company issued 2,650,000 and 2,000,000 shares of common stock to the Company’s CEO and director and four board of directors’ members, the shares were valued and recognized compensation of $6,735 and $5,290, respectively.
During the year ended November 30, 2024, the Company recognized $6,000 and paid $4,500 office rent expenses to a company controlled by a related party.
On July 13, 2024, the Company entered into a Revenue Sharing agreement with a company controlled by a related party, pursuant to which the Company acquired 5% net revenue generated from two contracts of Medicare enrollees, life and annuity insurance, in exchange for 133,334 shares of common stock, valued at $337. For the period of July 13,2024 (inception) to November 30, 2024, the Company recognized review sharing of $39.
At November 30, 2024 and 2023, the Company owed $16,166 and $16,465, respectively, to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director. The amount is unsecured, non-interest bearing and due on demand.
NOTE 5 - COMMON STOCK
Common Stock
The Company has authorized common shares of 750,000,000, par value $0.001 per share. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights.
During the year ended November 30, 2023, the Company issued following shares:
·
10,000,000 shares of common stock against amount owed to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, valued at $26,448.
·
2,000,000 shares of common stock as stock - based compensation to the Company’s CEO and director, valued at $5,290.
·
1,400,000 shares of common stock to the Company’s board advisors as advisory fees, valued at $3,703.
·
10,000 shares of common stock for settlement of debt to a vendor, valued at $26.
During the year ended November 30, 2024, the Company issued following shares:
·
2,000,000 shares of common stock to the Company’s CEO and director, valued at $5,056.
·
650,000 shares of common stock to the Company’s board of directors, valued at $1,679.
·
430,000 shares of common stock to the Company’s advisory board members, valued at $1,124.
·
100,000 shares of common stock against management fees payable to the Company’s CEO and director, valued at $262.
·
102,200 shares of common stock against amounts owed to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, valued at $268.
·
133,334 shares of common stock issued for Medicare contracts asset, a revenue sharing agreement - related party, valued at $337
·
1,333,333 shares of common stock issued for software and development acquisition, valued at $3,371
There were 107,782,190 and 103,033,323 shares of common stock issued and outstanding as of November 30,2024 and 2023, respectively.
NOTE 6 - LOSS PER SHARE
The following represents of the numerators and denominators of the basic and diluted loss per shares for the years ended November 30,2024 and 2023:
November 30
November 30
Net loss
$ (85,697 )
$ (136,789 )
Basic and diluted weighted average common shares outstanding
104,814,980
92,509,487
Basic and diluted loss per common share
(0.00 )
(0.00 )
NOTE 7 - INCOME TAXES
The Company’s tax expense differs from the “expected” tax expense for Federal income tax purposes (computed by applying the United States Federal tax rate of 21% to loss before taxes), as follows:
For the Years Ended
November 30,
Income tax expense at statutory rate
$ (17,996 )
$ (26,837 )
Change in valuation allowance
17,996
26,837
Income tax expense per books
$ -
$ -
The Company assesses the likelihood that deferred tax assets will not be realized ASC 740, “Income Taxes” requires that a valuation allowance be established when it is “more likely than not” that all, or a portion of, deferred tax assets will not be realized. A review of all available positive and negative evidence needs to be considered, including the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. After consideration of all the information available, management believes that uncertainty exists with respect to future realization of its deferred tax assets and has, therefore, established a full valuation allowance as of November 30, 2024.
The tax effect of significant components of the Company’s deferred tax assets and liabilities at November 30, 2024 and 2023, respectively, are as follows:
For the Years Ended
November 30,
NOL Carryover
$ 98,128
$ 80,132
Valuation allowance
(98,128 )
(80,132 )
Net deferred tax asset
$ -
$ -
As of November 30, 2024, the Company had $476,274 in net operating losses (“NOLs”) that may be available to offset future taxable income, NOLs generated in tax years prior to July 31, 2018, can be carryforward for twenty years, whereas NOLs generated after July 31, 2018, can be carryforward indefinitely. In accordance with Section 382 of the U.S. Internal Revenue Code, the usage of the Company’s net operating loss carry forwards are subject to annual limitations following greater than 50% ownership changes.
The Company’s tax returns are subject to examination by tax authorities.
NOTE 8 - CONCENTRATION
As of November 30, 2024 and for the year ended November 30, 2024, customer and revenue concentrations (more than 10%) were 100% related to one revenue sharing agreement with a related party.
NOTE 9 - SUBSEQUENT EVENTS
The Company has evaluated the existence of events and transactions subsequent to the balance sheet date through the date the financial statements were issued and has determined that there were no significant subsequent events or transactions that would require recognition or disclosure in the financial statements.
On January 24, 2025, the Company entered into a Letter of Intent (LOI) with AMJ Global Entertainment, LLC, controlled by the Company’s CEO and director for acquisition 100% of AMJ Global Entertainment’s 25% of target’s equity stake in a company controlled by a related party for amount of $1,000,000 in cash with payment term of two years.
On January 27, 2025, the Company entered into a share exchange agreement with an entity for selling 5,000,000 restricted shares of common stock for 2,000,000 shares of common stock of Diamond Lake Mineral, Inc. a public company under laws of the state of Utah. As of filling of these consolidate financial statements, the transactions have not been completed.

---

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
Item 9. Changes In and Disagreements with Accountants on Accounting and Financial Disclosure
We have had no disagreements with our accountants required to be disclosed pursuant to Item 304 of Regulation S-K.

---

ITEM 9A. CONTROLS AND PROCEDURES
Item 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company’s Chief Executive Officer and Chief Financial Officer has evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of and for the year ended November 30, 2024, covered by this Form 10-K. Based upon such evaluation, the Chief Executive Officer and Chief Financial Officer has concluded that, as of the end of such period, the Company’s disclosure controls and procedures were not effective as required under Rules 13a-15(e) and 15d-15(e) under the Exchange Act.
Management’s Annual Report on Internal Control over Financial Reporting
The management of the Company is responsible for the preparation of the financial statements and related financial information appearing in this Annual Report on Form 10-K. The financial statements and notes have been prepared in conformity with accounting principles generally accepted in the United States of America. The management of the Company is also responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. A company’s internal control over financial reporting is defined as a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:
·
Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;
·
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and the board of directors of the Company; and
·
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s disclosure controls and internal controls will prevent all error and all fraud. Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable, not absolute, assurance that the objectives of the control system are met and may not prevent or detect misstatements. Further, over time, control may become inadequate because of changes in conditions or the degree of compliance with the policies or procedures may deteriorate.
With the participation of the Chief Executive Officer and Chief Financial Officer, our management evaluated the effectiveness of the Company’s internal control over financial reporting as of November 30, 2024, based upon the framework in Internal Control -Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in 2013. Based on that evaluation, our management has concluded that, as of November 30, 2024, the Company had material weaknesses in its internal control over financial reporting and the Company’s internal control over financial reporting was not effective. Specifically, management identified the following material weaknesses at November 30, 2024:
1.
Lack of oversight by independent directors in the establishment and monitoring of required internal controls and procedures;
2.
Lack of functioning audit committee, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures;
3.
Insufficient personnel resources within the accounting function to segregate the duties over financial transaction processing and reporting and to allow for proper monitoring controls over accounting;
4.
Insufficient written policies and procedures over accounting transaction processing and period end financial disclosure and reporting processes.
To remediate our internal control weaknesses, management intends to implement the following measures:
·
The Company will add sufficient number of independent directors to the board and appoint an audit committee.
·
The Company will add sufficient knowledgeable accounting personnel to properly segregate duties and to effect a timely, accurate preparation of the financial statements.
·
Upon the hiring of additional accounting personnel, the Company will develop and maintain adequate written accounting policies and procedures.
The additional hiring is contingent upon the Company’s efforts to obtain additional funding through equity or debt for its continued operational activities and corporate expenses. Management provides no assurances that it will be able to do so.
We understand that remediation of material weaknesses and deficiencies in internal controls are a continuing work in progress due to the issuance of new standards and promulgations. However, remediation of any known deficiency is among our highest priorities. Our management will periodically assess the progress and sufficiency of our ongoing initiatives and make adjustments as and when necessary.
As a smaller reporting company, we are not required to provide, and this annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.
Changes in Internal Control over Financial Reporting
Except as set forth above, there were no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on the Effectiveness of Controls
The Company’s management, including the CEO and CFO, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of the control system must reflect that there are resource constraints and that the benefits must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

---

ITEM 9B. OTHER INFORMATION
Item 9B. Other Information.
None.

---

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Item 10. Directors, Executive Officers and Corporate Governance.
The following table sets forth information with respect to persons who are serving as directors and officers of the Company. Each director holds office until the next annual meeting of shareholders or until his successor has been elected and qualified.
Name
Age
Position
Dr. Arthur Malone, Jr.(1)
Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, Director
__________
(1) Appointed on November 9, 2015.
Biographies of Directors and Officers
The following is a brief account of the education and business experience during at least the past five years of each director, executive officer and key employee of our company, indicating the person’s principal occupation during that period, and the name and principal business of the organization in which such occupation and employment were carried out.
Dr. Arthur “Art” Malone, Jr.
From 2010 through the current date, Dr. Malone has been an entrepreneur, whether it be from investing in public and private companies to creating business opportunities for those not as fortunate, to advising public or private companies on corporate structure. Dr. Malone was formerly the Chairman and CEO of Songstagram, a mobile app company, that he resigned from, and which sold its interests in licensing agreements to a publicly traded company, bBooth, Inc., and formerly the Chairman and CEO of Medresponse Corp. (f/k/a Merecot Corp., MEDR) in 2015 when he sold his interests in November 2015. Dr. Malone, through his company, AMJ Global, has also created a clothing line as well as an entertainment company, and Dr. Malone taught over 5 years at Channel Islands Bible College. Dr. Malone attended the University of Washington where he studied Criminal Law and Sociology. Dr. Malone also attended Kings Seminary as well as Channel Islands Bible College. Dr. Malone holds a Bachelor’s Degree, as well as two Masters Degrees, and a Ph.D. The Company believes that Dr. Malone’s extensive experience in the technology sector and with small public companies qualifies him to serve as a director of the Company. The terms of Dr. Malone’s employment have not yet been determined. Dr. Malone, through AMJ Global LLC and AMJ Global Entertainment LLC, owns approximately 82.88% of the voting securities of the Company as of February 23, 2024.
Our directors are elected at the annual meeting of the shareholders, with vacancies filled by the Board of Directors, and serve until their successors are elected and qualified, or their earlier resignation or removal. Officers are appointed by the board of directors and serve at the discretion of the board of directors or until their earlier resignation or removal. Any action required can be taken at any annual or special meeting of stockholders of the corporation which may be taken without a meeting, without prior notice and without a vote, if consent of consents in writing setting forth the action so taken, shall be signed by the holders of the outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and shall be delivered to the corporation by delivery to its registered office, its principle place of business, or an officer or agent of the corporation having custody of the book in which the proceedings of meetings are recorded.
As we have recently devoted efforts to exploring the intersection of technology and wholistic technology-based health treatments for a variety of mental health conditions, from autism to dementia and Alzheimer’s, we have also retained Board of Advisors composed of advisors we believe are competent to advise us regarding technology, sports health issues and treatments, and PTSD.
Indemnification of Directors and Officers
Section 78.138 of the Nevada Revised Statutes (“NRS”) provides that a director or officer will not be individually liable unless it is proven that (i) the director’s or officer’s acts or omissions constituted a breach of his or her fiduciary duties, and (ii) such breach involved intentional misconduct, fraud or a knowing violation of the law. Section 78.7502 of NRS permits a company to indemnify its directors and officers against expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with a threatened, pending or completed action, suit or proceeding if the officer or director (i) is not liable pursuant to NRS 78.138 or (ii) acted in good faith and in a manner the officer or director reasonably believed to be in or not opposed to the best interests of the corporation and, if a criminal action or proceeding, had no reasonable cause to believe the conduct of the officer or director was unlawful. Section 78.751 of NRS permits a Nevada company to indemnify its officers and directors against expenses incurred by them in defending a civil or criminal action, suit or proceeding as they are incurred and in advance of final disposition thereof, upon receipt of an undertaking by or on behalf of the officer or director to repay the amount if it is ultimately determined by a court of competent jurisdiction that such officer or director is not entitled to be indemnified by the company. Section 78.751 of NRS further permits the company to grant its directors and officers additional rights of indemnification under its articles of incorporation or bylaws or otherwise. Section 78.752 of NRS provides that a Nevada company may purchase and maintain insurance or make other financial arrangements on behalf of any person who is or was a director, officer, employee or agent of the company, or is or was serving at the request of the company as a director, officer, employee or agent of another company, partnership, joint venture, trust or other enterprise, for any liability asserted against him and liability and expenses incurred by him in his capacity as a director, officer, employee or agent, or arising out of his status as such, whether or not the company has the authority to indemnify him against such liability and expenses.
Our Articles of Incorporation provide that no director or officer of the Company will be personally liable to the Company or any of its stockholders for damages for breach of fiduciary duty as a director or officer; provided, however, that the foregoing provision shall not eliminate or limit the liability of a director or officer (i) for acts or omissions which involve intentional misconduct, fraud or knowing violation of law, or (ii) the payment of dividends in violation of Section 78.300 of NRS. In addition, our Bylaws implement the indemnification and insurance provisions permitted by Chapter 78 of the NRS by providing that the Company shall indemnify its directors to the fullest extent permitted by the NRS and may, if and to the extent authorized by the board of directors, so indemnify its officers and any other person whom it has the power to indemnify against liability, reasonable expense or other matter whatsoever; and the Company may at the discretion of the board of directors purchase and maintain insurance on behalf of any person who holds or who has held any position identified in the paragraph above against any and all liability incurred by such person in any such position or arising out of his status as such.
Insofar as indemnification by us for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling the company pursuant to provisions of our articles of incorporation and bylaws, or otherwise, we have been advised that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification by such director, officer or controlling person of us in the successful defense of any action, suit or proceeding is asserted by such director, officer or controlling person in connection with the securities being offered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
Director Compensation
During the fiscal years ended November 30, 2024, and 2023, we did not have an independent director. Directors that were employees (i.e., Dr. Malone, our sole officer and director) were paid following:
During the years ended November 30, 2024, and 2023, the Company’s board of directors approved the issuance of 2,000,000 and 2,000,000 shares of common stock as a one-time bonus to the Company’s CEO for services rendered as CEO and director, respectively. The Company recognized compensation of $5,056 and $5,290 for the issuance of 2,000,000 and 2,000,000 shares of common stock, respectively.
Board of Advisors
During the years ended November 30, 2024, and 2023, the Company’s board of directors approved issuing 430,000 and 1,400,000 shares of common stock to five and six advisory board members, respectively. The Company valued the shares and recognized compensation of $1,124 and $3,703 for the issuance of 430,000 and 1,4000,000 shares of common stock, respectively.
Involvement on Certain Material Legal Proceedings During the Last Five Years
No director, officer, significant employee or consultant has been convicted in a criminal proceeding, exclusive of traffic violations.
No bankruptcy petitions have been filed by or against any business or property of any director, officer, significant employee or consultant of the Company nor has any bankruptcy petition been filed against a partnership or business association where these persons were general partners or executive officers.
No director, officer, significant employee or consultant has been permanently or temporarily enjoined, barred, suspended or otherwise limited from involvement in any type of business, securities or banking activities.
No director, officer or significant employee has been convicted of violating a federal or state securities or commodities law.
Directors’ and Officers’ Liability Insurance
The Company does not have directors’ and officers’ liability insurance insuring our directors and officers against liability for acts or omissions in their capacities as directors or officers.
Code of Ethics
We intend to adopt a code of ethics that applies to our officers, directors and employees, including our principal executive officer and principal accounting officer, but have not done so to date due to our relatively small size. We intend to adopt a written code of ethics in the near future.
Corporate Governance and Board Independence
Our Board of Directors consists of one director and has not established a Nominating or Governance Committees as standing committees. The Board does not have an executive committee or any committees performing a similar function. We are not currently listed on a national securities exchange or in an inter-dealer quotation system that has requirements that a majority of the board of directors be independent.
Due to our lack of operations and size, and since we are not currently listed on a national securities exchange, we are not subject to any listing requirements mandating the establishment of any particular committees; all functions of a nominating/governance committee were performed by our whole board of directors. Our board of directors intends to appoint such persons and form such committees as are required to meet the corporate governance requirements imposed by the national securities exchanges as necessary. Our board of directors does not believe that it is necessary to have such committees at the early stage of the company’s development, and our board of directors believes that the functions of such committees can be adequately performed by the members of our board of directors.
We believe that our board of directors is capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. We believe that retaining an independent director who would qualify as an “audit committee financial expert” would be overly costly and burdensome and is not warranted in our circumstances given the early stages of our development and the fact that we have not generated any material revenues to date.
Board Leadership Structure and the Board’s Role in Risk Oversight.
The Board of Directors is led by a Chairman, and at this time our Chairman is our sole director and is also our Chief Executive Officer. Although our sole officer is our sole director, the Board believes that the most effective leadership structure at this time is not to separate the roles of Chairman and Chief Executive Officer. A combined structure provides the Company with a single leader who represents the company to our stockholders, regulators, business partners and other stakeholders, among other reasons set forth below.
·
This structure creates efficiency in the preparation of the meeting agendas and related Board materials as the Company’s Chief Executive Officer works directly with those individuals preparing the necessary Board materials and is more connected to the overall daily operations of the Company. Agendas are also prepared with the permitted input of the full Board of Directors allowing for any concerns or risks of any individual director to be discussed as deemed appropriate. The Board believes that the Company has benefited from this structure, and Mr. Perry’s continuation in the combined role of the Chairman and Chief Executive Officer is in the best interest of the stockholders.
·
The Company believes that the combined structure is necessary and allows for efficient and effective oversight, given the Company’s relatively small size, its corporate strategy and focus.
The Board of Directors does not have a specific role in risk oversight of the Company. The Chairman, President and Chief Executive Officer and other executive officers and employees of the Company provide the Board of Directors with information regarding the Company’s risks.

---

ITEM 11. EXECUTIVE COMPENSATION
Item 11. Executive Compensation
The table below sets forth, for our last two fiscal years, the compensation earned by our executive officers.
Option
Deferred
and
All Other
Name and
Compen-
Stock
Warrant
Compen-
Principal Position
Salary
sation
Bonus
Awards
Awards
sation
Total
Dr. Arthur Malone, Jr.(1)
$
-
$
-
$
-
$
5,056
$
-
$
-
$
5,056
Chief Executive Officer,
$
-
$
-
$
-
$
5,290
$
-
$
-
$
5,290
Board Members (2)
Rober Sturman
$
-
$
-
$
-
$
$
-
$
-
$
$
-
$
-
$
-
$
-
$
-
$
-
$
-
Veren Barkdull
$
-
$
-
$
-
$
$
-
$
-
$
$
-
$
-
$
-
$
-
$
-
$
-
$
-
Jesse Anglen
$
-
$
-
$
-
$
$
-
$
-
$
$
-
$
-
$
-
$
-
$
-
$
-
$
-
Adrian Neilson
$
-
$
-
$
-
$
$
-
$
-
$
$
-
$
-
$
-
$
-
$
-
$
-
$
-
Board of Advisors (3)
Paul Ring
$
-
$
-
$
-
$
$
-
$
-
$
$
-
$
-
$
-
$
-
$
-
$
-
$
-
Jerry Doby
$
-
$
-
$
-
$
$
-
$
-
$
$
-
$
-
$
-
$
-
$
-
$
-
$
-
Wendell Johnson
$
-
$
-
$
-
$
$
-
$
-
$
$
-
$
-
$
-
$
-
$
-
$
-
$
-
Alan Klitenic
$
-
$
-
$
-
$
$
-
$
-
$
$
-
$
-
$
-
$
-
$
-
$
-
$
-
Robert Stutman
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
$
-
$
-
$
Veren Barkdull
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
$
-
$
-
$
Rocky Wright
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
--
$
$
-
$
-
$
Roman Phifer
$
-
$
-
$
-
$
$
-
$
-
$
$
-
$
-
$
-
$
$
-
$
-
$
Jesse Anglen
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
$
-
$
-
$
Adrian Neilan
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
-
$
$
-
$
-
$
______________
(1)
Dr. Malone was appointed as CEO, CFO, Director, Secretary and Treasurer on November 9, 2015. Previously, he was a Director from July 7, 2015, through July 24, 2015. There is no employment agreement with Dr. Malone.
(2)
On March 26,2024, the Company appointed Robert Stutman, Veren Barkdull, Jesse Anglen and Adrian Neilan as members of Board of Directors.
(3)
(i) Between February 16, 2023, and March 24, 2023, the Company appointed the following individuals to its Board of Advisors: Robert Stutman, Adrian Neilan, Vern Barkdull, Rocky Wright, Roman Phifer, and Jesse Anglen.
(ii) On April 2,2024 and July 31,2024, the Company appointed the following individuals to its Board of Advisors: Jerry Doby, Paul Ring, Wendell Johnson and Alan Klitenic.
There are no current employment agreements between the Company and its current CEO and Director, Dr. Malone.
No retirement, pension, profit sharing, stock option or insurance programs or other similar programs have been adopted by us for the benefit of our officer or directors or employees.

---

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The following table sets forth information regarding the beneficial ownership of the Company’s common stock (and preferred stock) as of November 30, 2024, for (i) each person or entity who, to our knowledge, beneficially owns more than 5% of our common stock; (ii) each executive officer and named officer; (iii) each director; and (iv) all of our officers and directors as a group. Unless otherwise indicated in the footnotes to the following table, each of the stockholders named in the table has sole voting and investment power with respect to the shares of our common stock beneficially owned. Except as otherwise indicated, the address of each of the stockholders listed below is: c/o 11724 Ventura Blvd., Suite B, Studio City, California, 91604.
Name of Beneficial Owner
Number of
Shares Owned. (1)
Percentage
Owned. (1)
Dr. Arthur Malone, Jr.(2)
89,325,355
82.88 %
All officers and directors as a group (1 person)
89,325,355
82.88 %
____________
(1)
Applicable percentage of ownership is based on 107,782,190 total shares comprised of our common stock outstanding (as defined below) as of November 30, 2024.
(2)
Consists of 75,792,155 shares held in the name of AMJ Global Entertainment, LLC, and 13,533,200 shares held in the name of AMJ Global, LLC, both of which are entities controlled by Dr. Malone, with Dr. Malone having voting and dispositive power with respect to shares held in the names of the entities.

---

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Item 13. Certain Relationships and Related Transactions
On April 26, 2023, the Company entered into an assignment agreement with AMJ Global Entertainment, LLC, a Nevada limited liability company controlled by the Company’s CEO and director, pursuant to which AMJ Global Entertainment assigned to the Company 25% of the ownership rights to AMJ Global Entertainment’s intellectual property in connection with the “Blabeey” platform, including software, code and trade secrets at zero cost.
During the years ended November 30,2024 and 2023, AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director advanced to the Company an amount of $47,827 and $51,118, respectively, by paying for operating expenses on behalf of the Company, $820 and $0 in cash and repaid $307 and $0, respectively.
During the years ended November 30,2024 and 2023, the Company accrued management fees of $120,000 and $110,000, respectively.
During the years ended November 30,2024 and 2023, the Company’s board of directors approved the issuance of 102,200 and 10,000,000 shares of common stock for settlement of $48,639 and $45.751 due to AMJ Global Entertainment, LLC, a related party controlled by the Company’s CEO and director, respectively. The shares were valued at $268 and $26,448, resulting in a gain of settlement on debt of $48,371 and 19,302, respectively.
During the year ended November 30, 2024, the Company’s board of directors approved the issuance of 100,000 shares of common stock for settlement of $50,000 management fees payable to the Company’s CEO and director. The shares were valued at $262, resulting in a gain of settlement on debt of $49,738.
During the years ended November 30,2024 and 2023, the Company issued 430,000 and 1,400,000 shares of common stock to advisory board members, the shares were valued and recognized compensation of $1,124 and $3703, respectively.
During the years ended November 30,2024 and 2023, the Company issued 2,650,000 and 2,000,000 shares of common stock to the Company’s CEO and director and four board of directors’ members, the shares were valued and recognized compensation of $6,735 and $5,290, respectively.
During the year ended November 30, 2024, the Company recognized $6,000 and paid $4,500 office rent expenses to a company controlled by a related party.
On July 13, 2024, the Company entered into a Revenue Sharing agreement with a company controlled by a related party, pursuant to which the Company acquired 5% net revenue generated from two contracts of Medicare enrollees, life and annuity insurance, in exchange for 133,334 shares of common stock, valued at $337. For the period of July 13,2024 (inception) to November 30, 2024, the Company recognized review sharing of $39.
Transactions with Related Persons
Director Independence
We currently do not have any independent directors, as the term “independent” is defined in Section 803A of the NYSE Amex LLC Company Guide. Since the Over the Counter Pink (“OTCPK”) does not have rules regarding director independence, the Board makes its determination as to director independence based on the definition of “independence” as defined under the rules of the New York Stock Exchange (“NYSE”) and American Stock Exchange (“Amex”).

---

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
Item 14. Principal Accounting Fees and Services.
The following table sets forth the fees billed by our principal independent accountants for 2024 and 2023, for the categories of services indicated.
Years Ended
November 30,
Category
Audit Fees
$ 20,000
$ 16,000
Audit Related Fees
-
-
Tax Fees
-
-
All Other Fees
-
-
Total
$ 20,000
$ 16,000
Audit fees. Consists of fees billed for the audit of our annual financial statements and review of our interim financial information and services that are normally provided by the accountant in connection with year-end and quarter-end statutory and regulatory filings or engagements.
Audit-related fees. Consists of fees billed for services relating to review of other regulatory filings including registration statements, periodic reports and audit related consulting.
Tax fees. Consists of professional services rendered by our principal accountant for tax compliance, tax advice and tax planning.
Other fees. Other services provided by our accountants.

---

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
Item 15. Exhibits, Financial Statement Schedules
See the Exhibit Index following the signature page of this Registration Statement, which Exhibit Index is incorporated herein by reference.
Number
Description
3.1
Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
3.2
Certificate of Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed on April 26, 2023)
3.3
Bylaws (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
10.1
Assignment of Rights Agreement between the Company and AMJ Global (incorporated by reference to our Current Report on Form 8-K filed on November 12, 2015)
10.2
Assignment Agreement, dated as of April 23, 2023, by and between AMJ Global Technology, and AMJ Global Entertainment, LLC (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K, filed on April 26, 2023)
10.3
Board Member Agreement, by and between the Company and Adrian Neilan, dated March 26, 2024 (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on April 1, 2024)
10.4
Board Member Agreement, by and between the Company and Jesse Anglen, dated March 26, 2024 (incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K filed on April 1, 2024)
10.5
Board Member Agreement, by and between the Company and Vern Barkdull, dated March 26, 2024 (incorporated by reference to Exhibit 10.4 to our Current Report on Form 8-K filed on April 1, 2024)
10.6
Revenue Sharing Agreement, by and between the Company and Dark Bull, dated July 13, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on July 18, 2024)
10.7
Software Purchase and Development Agreement between AMJ Global Technology and Dataark Systems LLC, dated August 25, 2024 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on August 27, 2024)
31.1/31.2*
Certification of Chief Executive Officer and Chief Financia Officer of Kange Corp. required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1/32.2*
Certification of Chief Executive Officer and Chief Financial Officer of Kange Corp. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 Of 18 U.S.C. 63
101*
Inline XBRL Document Set for the financial statements and accompanying notes in Part II, Item 8, “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K.
104*
Inline XBRL for the cover page of this Annual Report on Form 10-K, included in the Exhibit 101 Inline XBRL Document Set.
__________
* Filed herewith